New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Scientists discover new way to defeat invisible cancer cells

Scientists discover new way to defeat invisible cancer cells

Modern immunotherapies boost the body's own defenses against cancer. They activate killerT cellsof the immune system that can specifically recognize and destroy cancer cells. In many p
World medicine November 21,2023
Scientists discover new way to defeat invisible cancer cells

Scientists discover new way to defeat invisible cancer cells

Modern immunotherapies boost the body's own defenses against cancer. They activate killerT cellsof the immune system that can specifically recognize and destroy cancer cells. In many p
World medicine November 21,2023
Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because
World medicine November 21,2023
Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because
World medicine November 21,2023
2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by accelerating research breakthroughs, today announced the 19 recipients of its 2023 research
World medicine November 21,2023
2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by accelerating research breakthroughs, today announced the 19 recipients of its 2023 research
World medicine November 21,2023
New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.Results from an international clinical trial, published June 15 inThe Lancet,
World medicine November 21,2023
New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.Results from an international clinical trial, published June 15 inThe Lancet,
World medicine November 21,2023
Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.Researchers at Imperial College London have c
World medicine November 21,2023
Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.Researchers at Imperial College London have c
World medicine November 21,2023
Study shows link between diet and the risk of HPV-related cancer

Study shows link between diet and the risk of HPV-related cancer

A study conducted by LSU Health New Orleans' Schools of Public Health and Medicine faculty reports that diet contributes to HPV infection leading to cervical cancer. Results are published in the&n
World medicine November 21,2023
Study shows link between diet and the risk of HPV-related cancer

Study shows link between diet and the risk of HPV-related cancer

A study conducted by LSU Health New Orleans' Schools of Public Health and Medicine faculty reports that diet contributes to HPV infection leading to cervical cancer. Results are published in the&n
World medicine November 21,2023
Study of immunotherapy for brain cancer metastases shows promising results

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patien
World medicine November 21,2023
Study of immunotherapy for brain cancer metastases shows promising results

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patien
World medicine November 21,2023
Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

Healthy cells work hard to maintain the integrity of our DNA, but occasionally, a chromosome can get separated from the others and break apart during cell division. The tiny fragments of DNA then get
World medicine November 21,2023
Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

Healthy cells work hard to maintain the integrity of our DNA, but occasionally, a chromosome can get separated from the others and break apart during cell division. The tiny fragments of DNA then get
World medicine November 21,2023
New insights into how aggressive cancer cells proliferate and propagate the disease

New insights into how aggressive cancer cells proliferate and propagate the disease

Not all cancer metastases have the same destructive effect. Researchers demonstrate different mechanisms in experiments.A recent paper in "Cell Reports", co-led by Dr. Christina Scheel from
World medicine November 21,2023
New insights into how aggressive cancer cells proliferate and propagate the disease

New insights into how aggressive cancer cells proliferate and propagate the disease

Not all cancer metastases have the same destructive effect. Researchers demonstrate different mechanisms in experiments.A recent paper in "Cell Reports", co-led by Dr. Christina Scheel from
World medicine November 21,2023
Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM)
World medicine November 21,2023
Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM)
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com